Engler D, Chad D, Jackson I M
J Clin Invest. 1982 Jun;69(6):1310-20. doi: 10.1172/jci110571.
These studies have been undertaken to evaluate the role of the brain noradrenergic and dopaminergic pathways in the regulation of the secretion of thyrotropin-releasing hormone (TRH) in the central nervous system (CNS) and pancreas of the neonatal rat. When CNS stores of norepinephrine (NE) were selectively reduced by the subcutaneous administration of the dopamine-beta-hydroxylase inhibitor FLA-63, TRH concentrations were significantly reduced throughout the brain. However, when CNS stores of both NE and dopamine (DA) were depleted by the subcutaneous administration of the tyrosine hydroxylase inhibitor alpha-methyl-rho-tyrosine (alpha-MT), TRH concentrations in the brain were not significantly altered.FLA-63 and alpha-MT did not significantly reduce pancreatic catecholamine concentrations, indicating that in the basal state, these agents predominantly deplete central catecholamine stores. Nevertheless, pancreatic TRH concentrations were markedly reduced by FLA-63, and this effect was significantly attenuated by the simultaneous intracerebroventricular (icv) administration of NE. In contrast to the effects of FLA-63, alpha-MT caused a significant increase in pancreatic TRH concentrations, and this effect was significantly lessened by icv DA. To determine whether the sympathetic nervous system might be one route by which these central effects are mediated, a chemical sympathectomy was induced with guanethidine. This treatment selectively reduced pancreatic concentrations of NE, and caused a marked increase in pancreatic TRH concentrations. FROM THESE OBSERVATIONS, WE CONCLUDE THE FOLLOWING: (a) within the central nervous system, both NE and DA are involved in regulating brain TRH secretion or biosynthesis, and the direction of action of these two neurotransmitters appears to be opposite; (b) pancreatic TRH secretion or biosynthesis is also controlled by the brain noradrenergic and dopaminergic systems, and the net effects of each of these pathways appears to be opposite; (c) at least one route by which impulses from the brain may travel and modulate pancreatic TRH secretion or biosynthesis is by the sympathetic nervous system.
开展这些研究是为了评估大脑去甲肾上腺素能和多巴胺能通路在新生大鼠中枢神经系统(CNS)和胰腺中促甲状腺激素释放激素(TRH)分泌调节中的作用。当通过皮下注射多巴胺-β-羟化酶抑制剂FLA-63选择性降低中枢神经系统中去甲肾上腺素(NE)的储存量时,整个大脑中的TRH浓度显著降低。然而,当通过皮下注射酪氨酸羟化酶抑制剂α-甲基-对酪氨酸(α-MT)使中枢神经系统中NE和多巴胺(DA)的储存量都耗尽时,大脑中的TRH浓度没有显著改变。FLA-63和α-MT并没有显著降低胰腺儿茶酚胺浓度,这表明在基础状态下,这些药物主要消耗中枢儿茶酚胺储存量。尽管如此,FLA-63使胰腺TRH浓度显著降低,而通过脑室内(icv)同时注射NE可显著减弱这种作用。与FLA-63的作用相反,α-MT使胰腺TRH浓度显著增加,而icv注射DA可显著减轻这种作用。为了确定交感神经系统是否可能是介导这些中枢作用的一条途径,用胍乙啶进行了化学去交感神经支配。这种处理选择性降低了胰腺中NE的浓度,并使胰腺TRH浓度显著增加。基于这些观察结果,我们得出以下结论:(a)在中枢神经系统内,NE和DA都参与调节大脑TRH的分泌或生物合成,并且这两种神经递质的作用方向似乎相反;(b)胰腺TRH的分泌或生物合成也受大脑去甲肾上腺素能和多巴胺能系统的控制,并且这些通路各自的净效应似乎相反;(c)大脑发出的冲动可能通过并调节胰腺TRH分泌或生物合成的至少一条途径是通过交感神经系统。